Regulated Information
Elis closes the acquisition of Moderna Holding BV in the Netherlands
Press releases50.31 KB • February, 26th 2024
Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 01 2024
Voting rights75.69 KB • February, 22nd 2024
Full-year 2023 revenue (presentation)
Financial presentations2.67 MB • January, 30th 2024
Full-year 2023 revenue (press release)
Financial releases191.13 KB • January, 30th 2024
Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 12 2023
Voting rights61.25 KB • January, 17th 2024
Elis announces the signing of an agreement for the acquisition of Moderna Holding BV in the Netherlands
Press releases92.87 KB • January, 10th 2024
Termination and implementation of the liquidity contract
Share buy-back programs and liquidity contract58.38 KB • January, 2nd 2024
Appointment of BW Gestão de Investimentos as member of Elis Supervisory Board
Press releases59.85 KB • December, 18th 2023
Disclosure of the number of shares forming the capital and of the number of voting rights as of 30 11 2023
Voting rights61.18 KB • December, 11th 2023
S&P Global Ratings upgrades Elis to an Investment Grade credit BBB- rating
Press releases85.5 KB • November, 17th 2023